A new algorithm may be used to tailor treat-and-extend regimens with intravitreal anti-VEGF agents to individual patients with retinal disease, according to a study.The algorithm was developed using data from 11 published studies on treat-and-extend re…
ZEISS Sets the Pace in OCT Innovation with First FDA 510(k) Clearance of OCT Angiography Technology
DUBLIN, Calif.–(BUSINESS WIRE)–ZEISS sets the pace in OCT innovation with the FDA 510(k) clearance of AngioPlex OCT Angiography, the first next generation vascular imaging technology approved in the U.S.
Eydie Miller-Ellis, MD, named president of JCAHPO
The Joint Commission on Allied Health Personnel in Ophthalmology has named Eydie Miller-Ellis, MD, as the organization’s 24th president, according to a press release.“I am honored to serve as JCAHPO’s president for the next 2 years and look forward to leading the organization into a future that draws on, substantiates and continues JCAHPO’s history as a visionary in the field of allied ophthalmic health certification and education,” Miller-Ellis said in the release. “I am privileged to serve as the chief volunteer and strive to advance the standards set by my prestigious predecessors.”
Dementia of the Eye: The Role of Amyloid Beta in AMD
This review offers new insights into the involvement of amyloid beta in the degenerative processes in the retina, particularly in age-related macular degeneration. Eye
Publication Exclusive: Significant advantages abound for young patients who have laser vision correction
Greg has touched on the four most significant advantages of having laser vision correction — quality of life, better vision, cost savings and safety — while also discussing that a full 90% of the population has reached ocular maturity by age 18 years and is ready for refractive surgery.He also mentions the very high prevalence of laser vision correction in the four branches of the armed services and previews our article in an upcoming issue of Journal of Cataract and Refractive Surgery about refractive surgery in refractive surgeons, in which we show … well, you will have to wait for that one.
Gene therapy fully restores vision in mouse model of Leber congenital amaurosis
Mice lacking the protein retGC1, which is deficient in humans suffering Leber congenital amaurosis-1 (LCA1), a disorder that causes severe visual impairment beginning in infancy, received gene…